The "A+H" model is favored, and the pace of A-share companies listing in Hong Kong is accelerating.

Recently, Hengrui Medicine and Contemporary Amperex Technology Co., Ltd. announced that they have officially passed the listing hearing on the Hong Kong Stock Exchange. At the same time, companies such as Siles, Zoomlion Electric, and Dongpeng Beverage have also announced their plans to list in Hong Kong. Building an international capital operation platform and strengthening global layout is the common goal of many A-share companies listing in Hong Kong. Industry insiders say that in recent years, A-share companies have shown increasing interest in "A+H" listings. Against the background of the Hong Kong Stock Exchange and the Securities and Futures Commission of Hong Kong opening up fast channels for high market value A-share listed companies, as well as A-share companies continuing to promote their internationalization strategies, the "A+H" listing model continues to be favored, injecting strong momentum into the development of the Hong Kong IPO market.